Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.490, 2005-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bevacizumab costly for ovarian cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 624, 2011-01 ,pp. :
Access to resources
Recommend
Bevacizumab in Ovarian Cancer: Unanswered Questions
Drugs, Vol. 72, Iss. 7, 2012-05 ,pp. :
The Role of Bevacizumab in Advanced Epithelial Ovarian Cancer
Current Pharmaceutical Design, Vol. 18, Iss. 25, 2012-07 ,pp. :
Sunitinib soars ahead in renal cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 580, 2009-01 ,pp. :